Your browser doesn't support javascript.
loading
He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway.
Kan, Jun; Fu, Biqian; Zhou, Ruisheng; Zhou, Daihan; Huang, Yufang; Zhao, Hongwei; Zhang, Yunlong; Rong, Yuming; Dong, Jun; Xia, Liangping; Liu, Shanshan; Huang, Qiuling; Wang, Nannan; Ning, Na; Zhang, Bei; Zhang, Enxin.
Afiliación
  • Kan J; Department of VIP Region, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou
  • Fu B; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen 518000, China.
  • Zhou R; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Zhou D; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Huang Y; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Zhao H; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Zhang Y; Key Laboratory of Neuroscience, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Rong Y; Department of VIP Region, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
  • Dong J; Department of VIP Region, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
  • Xia L; Department of VIP Region, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
  • Liu S; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou 510530, China.
  • Huang Q; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou 510530, China.
  • Wang N; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou 510530, China.
  • Ning N; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou 510530, China. Electronic address: 330288475@qq.com.
  • Zhang B; Department of VIP Region, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: zhangbei@sysucc.org.cn.
  • Zhang E; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen 518000, China. Electronic address: ergep53@126.com.
Phytomedicine ; 94: 153821, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34752967
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article